Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
concetta.potenza@uniroma1.it
Concetta Potenza
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE E BIOTECNOLOGIE MEDICO-CHIRURGICHE
E-mail:
concetta.potenza@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
A curious case of opticneuritis in hidradenitis suppurativa patient, successfullytreated with adalimumab
EXPERIMENTAL DERMATOLOGY
2021
Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis. The LION real-life multicenter prospective observational cohort study
DERMATOLOGIC THERAPY
2021
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa. Results of a prospective European cohort study
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
2021
The clinical spectrum of COVID-19–associated cutaneous manifestations. An Italian multicenter study of 200 adult patients
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
2021
Treat-to-target approach for the management of patients with moderate-to-severe plaque psoriasis. Consensus recommendations
DERMATOLOGY AND THERAPY
2021
Secukinumab improves patient perception of anxiety and depression in patients with moderate to severe psoriasis. A post hoc analysis of the SUPREME study
ACTA DERMATO-VENEREOLOGICA
2021
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy
EXPERT OPINION ON BIOLOGICAL THERAPY
2021
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 pandemic. Risk analysis from the PSO-BIO-COVID observational study
EXPERT OPINION ON BIOLOGICAL THERAPY
2021
Guselkumab. An anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis
EUROPEAN JOURNAL OF DERMATOLOGY
2021
Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa. Results from an Italian multicentric retrospective study in a real-life setting
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
2021
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma
EUROPEAN JOURNAL OF CANCER
2021
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in italy. data from the DA-COVID-19 registry
ALLERGY
2021
Ingenol mebutate therapy in erythroplasia of Queyrat: a new approach
ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY
2021
Aesthetic treatments in cancer patients
CLINICAL, COSMETIC AND INVESTIGATIONAL DERMATOLOGY
2021
Advantages of tailored isotretinoin treatment in moderate to severe acne: real-life data
FRONTIERS IN PHARMACOLOGY
2021
Erythrodermic psoriasis successfully treated with Anti IL-17. A case series
ACTA DERMATOVENEROLOGICA CROATICA
2021
Erythroplasia of Queyrat treated with methyl aminolevulinate-photodynamic therapy
GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA
2020
IL-17 and its role in inflammatory, autoimmune, and oncological skin diseases. State of art
INTERNATIONAL JOURNAL OF DERMATOLOGY
2020
Transitory auricular nodules. A peculiar adverse reaction in actinic keratosis field treatment
INTERNATIONAL JOURNAL OF DERMATOLOGY
2020
A case of hidradenitis suppurativa successfully treated with apremilast in a patient with psoriasis and SAMPUS
DERMATOLOGIC THERAPY
2020
« prima
< precedente
1
2
3
4
5
6
7
seguente ›
ultima »
ERC
LS4_1
LS4_6
Interessi di ricerca
Keywords
clinical trial
Progetti di Ricerca
Tumor microenvironment in melanoma treatment
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma